Curriculum vitae for mark cushman - Purdue College of Pharmacy ...

Mark Cushman
27. Mark S. Cushman and Martin M. Conda-Sheridan, "Design, Synthesis, and Biological
Evaluation of Indenoisoquinoline Rexinoids with Chemopreventive Potential,"
Application No. 61/771,544, filed March 1, 2013.
Patent Applications:
1. "New Anti-HIV Compounds Belonging to Aurintricarboxylic Acid", U. S. Patent
Application US 431,568, 15 Apr 1990, Appl. 03 Nov. 1989, NITS Order No. PAT-
APPL-7-431 568. A foreign filing of this patent has also been completed.
2. "Stilbene Derivatives as Anticancer Agents", U. S. Patent Application US 887,725, May
21, 1992.
3. "1,2-Dihydroellipticines with Activity Against CNS Specific Cancer Cell Lines", U. S.
Patent Application Serial No. 07/956,903, October 2, 1992.
4. "Cosalane and Related Compounds Having Activity Against AIDS and AIDS-Related
Infections," U.S. Patent Application Serial No. 08/029,415, filed March 10, 1993.
5. "Compounds with Activity Against AIDS and Related Infections," International Patent
Application No. PCT/US94/01429, September 15, 1994. Published as WIPO Publication
No. WO 94/20519.
6. Robert J. D'Amato, Mark Cushman, Rudiger D. Haugwitz, and Ravi K. Varma,
"Estrogenic Compounds as Antiangiogenic Agents," U.S. Patent Application Serial No.
09-154,322, September 16, 1998.
7. Adelbert Bacher, Mark S. Cushman, Klaus Kis, Jeffrey Mihalic, Donglai Yang, Farahnaz
Mavandadi, and Karl B. Kugelbrey, "Inhibitoren der Biosynthese von Vitamin B2 und
Verfahren zu ihrer Herstellung," German Patent Application No. 199 03 736.1, January
28, 1999.
8. Mark S. Cushman, Ankush B. Argade, Rudiger D. Haugwitz, and Rajesh Devraj,
"Brefeldin A Derivatives," International Patent Application No. PCT/US98/27000,
December 18, 1998.
9. Adelbert Bacher, Mark S. Cushman, Klaus Kis, Jeffrey Mihalic, Donglai Yang, Farahnaz
Mavandadi, and Karl B. Kugelbrey, "Inhibitoren der Biosynthese von Vitamin B2 und
Verfahren zu ihrer Herstellung," International Patent Application No.
PCT/EP2000/00638, January 27, 2000.
10. Mark S. Cushman, Pamela M. Nagafuji, Muthusamy Jayaraman, Yves G. Pommier,
Preparation of Diketoindenoisoquinolines as Antineoplastic Agents," International Patent
Application WO 99-US23900 19991014 (2000), European Patent Application No
12043/00.
11. Mark S. Cushman, Agustin Casimiro-Garcia, and William G. Rice, "Preparation of
Alkenyldiarylmethanes as Non-Nucleoside Reverse Transcriptase Inhibitors,"
International Patent Application Serial Number PCT/US99/00916. International filings
include P-97066.00.EP, P-97066.00.CA, and P-97066.00.JP, Application No. 2,317,942
(Japan) (2000).
12. Mark S. Cushman, Ankush B. Argade, Rudiger D. Haugwitz, and Rajesh Devraj,
"Preparation of Brefeldin A Derivatives for Use as Anticancer Agents," International
Patent Application PCT/US98/27000 (2000).
13. Mark S. Cushman, Pamela M. Nagafuji, Muthusamy Jayaraman, and Yves Pommier,
"Novel Indenoisoquinolines as Antineoplastic Agents," International Patent Application
WO 00/21537 (2000), European Patent Application No. E-030-1999/0-EP-05.
14. Mark Cushman and O. M. Zack Howard, "Cosalane Compounds and Methods for their
Use," P99.93.00.US, 7024/PUR-130 (2000), Application Number 09/726,101.
15. Mark S. Cushman, Pamela M. Nagafuji, Muthusamy Jayaraman, and Yves Pommier,
"Novel Indenoisoquinolines as Antineoplastic Agents," US Patent Application No.
09/807,340 (2001).
16. Ernest Hamel and Mark S. Cushman, "B-Homoestra-1,3,5(10)-trienes as Modulators of
Tubulin Polymerization," International Publication Number WO 01/30803 A1,
25